Inclusive of all taxes
EPIVALPRATE 200TAB by Dr Precision is a premium pharmaceutical-grade oral antiepileptic formulation containing 200 mg of Divalproex Sodium—a combination of sodium valproate and valproic acid. Specially designed for effective management of seizure disorders, bipolar disorder, and migraine prophylaxis, this formulation delivers sustained plasma levels for consistent therapeutic efficacy. Manufactured by BluepillExpress in WHO-GMP certified facilities, EPIVALPRATE 200TAB ensures impeccable quality, safety, and reliability for pharmaceutical businesses seeking contract manufacturing, private label branding, or bulk export opportunities. The unique balanced composition targets diverse seizure types including complex partial, absence, and generalized tonic-clonic seizures, while also stabilizing mood disorders and preventing migraine attacks in adult patients. Its action mechanism centers on augmenting brain GABA concentrations and modulating voltage-dependent sodium and calcium channels to reduce neuronal hyperexcitability. This sustained-release tablet is formulated for optimal tolerance and suitability in long-term therapy regimens, making it an essential product for neuropsychiatric treatment portfolios in B2B pharmaceutical industries.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Divalproex Sodium 200 mg (combination of sodium valproate and valproic acid) |
| Therapeutic Uses | Management of epilepsy, bipolar disorder (acute mania and maintenance), and migraine prophylaxis |
| Manufacturing Standard | Produced in WHO-GMP certified plants by BluepillExpress under Dr Precision label |
| Mechanism of Action | Increases GABA levels and modulates voltage-gated sodium and T-type calcium channels |
| Dosage Form | Oral tablet with sustained-release profile |
| Suitability | Appropriate for long-term therapy with regular clinical monitoring |
| Packaging & Usage | Ideal for third-party manufacturing, bulk export, private labeling, and government tenders |
| Target Seizure Types | Effective against complex partial, absence, and generalized tonic-clonic seizures |
| Safety | Clinically tested for tolerability with minimized gastric irritation when taken after meals |
| Export Documentation | Comes with full export documentation supporting international trade |
| Attributes | Description |
|---|---|
| Composition | Each tablet contains 200 mg of Divalproex Sodium (sodium valproate and valproic acid) |
| Indications | Epilepsy (partial, absence, generalized seizures), Bipolar disorder, Migraine prophylaxis |
| Pharmacological Action | Anticonvulsant and mood stabilizer with GABAergic and ion channel modulatory effects |
| Dosage Range | 200–1200 mg per day, depending on clinical condition |
| Administration | Oral, after meals to reduce gastric discomfort |
| Manufacturing Details | WHO-GMP certified manufacturing by BluepillExpress, Dr Precision label |
| Packaging | Available in bulk for third party manufacturing and export |
| Storage | Store in a cool, dry place away from direct sunlight |
| Shelf Life | As per pharmaceutical guidelines, typically 24 months |
| Regulatory Compliance | Complies with international pharmaceutical standards for neuropsychiatric drugs |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, EPIVALPRATE 200TAB is designed for third-party manufacturing, private label branding, and bulk export, supported by full export documentation and manufactured under WHO-GMP standards.
EPIVALPRATE 200TAB is effective against a broad spectrum of seizures including complex partial seizures, absence seizures, and generalized tonic-clonic seizures.
It increases brain GABA levels by inhibiting GABA transaminase and modulates voltage-gated sodium and T-type calcium channels to stabilize neural excitability.
Yes, this formulation is well tolerated and commonly used for long-term maintenance treatment of bipolar disorder with appropriate clinical monitoring.
It should be taken after meals to minimize gastric irritation, with regular serum level monitoring advised for optimal therapeutic outcomes.
Yes, EPIVALPRATE 200TAB is clinically proven to prevent migraine attacks in adult patients when used as a prophylactic treatment.
It is manufactured in WHO-GMP certified plants ensuring compliance with global pharmaceutical quality and safety standards.
Country Of Origin: India
EPIVALPRATE 200 TAB is a pharmaceutical-grade oral antiepileptic formulation containing Divalproex Sodium 200 mg, a combination of sodium valproate and valproic acid. It is commonly prescribed to manage seizure disorders, bipolar disorder, and migraine prophylaxis. Manufactured by BluepillExpress in certified WHO-GMP plants, EPIVALPRATE 200 ensures consistent quality, safety, and therapeutic efficacy—ideal for third-party manufacturing, bulk export, or private label branding.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
EPIVALPRATE 200 TAB is a clinically proven anticonvulsant and mood stabilizer that contains a carefully balanced composition of sodium valproate and valproic acid, chemically formulated to deliver 200 mg of Divalproex Sodium. This combination allows for sustained plasma concentrations, leading to effective control of neurological excitability and mood imbalances.
Divalproex Sodium is recognized as a broad-spectrum antiepileptic drug (AED), effective against various seizure types, including complex partial seizures, absence seizures, and generalized tonic-clonic seizures. It also serves a crucial role in managing acute episodes and long-term maintenance of bipolar disorder, particularly manic episodes, as well as preventing migraines in adults.
The mechanism of action of Divalproex Sodium involves increasing gamma-aminobutyric acid (GABA) levels in the brain—a major inhibitory neurotransmitter—thus stabilizing overactive nerve signals. Additionally, it modulates sodium and calcium channels, enhancing its antiepileptic effect.
BluepillExpress offers EPIVALPRATE 200 TAB as part of its comprehensive range of neuropsychiatric products, manufactured under WHO-GMP standards and supported by full export documentation. This product is ideal for contract manufacturing, third-party production, government tenders, and global distribution.
✅ Key Benefits
Effective in controlling a wide range of seizures
Used in the treatment and prevention of manic episodes in bipolar disorder
Prevents migraine attacks in adults
Well-tolerated with modified-release profile
Suitable for long-term therapy with proper monitoring
✅ Therapeutic Indications
Epilepsy: Partial seizures, absence seizures, generalized tonic-clonic seizures
Bipolar disorder: Acute mania and maintenance treatment
Migraine: Prophylaxis of migraine headaches
✅ Mechanism of Action
Divalproex Sodium increases GABA levels by inhibiting GABA transaminase and succinic semialdehyde dehydrogenase. It also reduces neuronal excitability through modulation of voltage-gated sodium channels and T-type calcium channels, reducing abnormal electrical activity in the brain.
✅ Dosage Information
Typical dose: 200–1200 mg/day depending on condition
Initial dose may vary based on weight and clinical need
Should be taken after meals to minimize gastric irritation
Regular serum level monitoring is advised for optimal therapeutic effect
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
